K-924 Phase III Confirmatory Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 293 participants.
Also called NCT04289649
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 293 participants
- Sponsor
- Registry
-
NCT04289649
-
- Other papers using this trial's data
- Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT04289649. Randomized; triple masking; primary purpose treatment. Start 2020-04-02 (actual); primary completion 2020-11-21 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- K-924 Phase III Confirmatory Study
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- K-924 LD
- Intervention (Drug)
- K-924 HD
- Intervention (Drug)
- K-924 LD Placebo
- Intervention (Drug)
- K-924 HD Placebo
- Lead sponsor
- Kowa Company, Ltd.
Record details
- Record id
cardio:ct-nct04289649- Content hash
71247c3162b3e31488dc226607fd5cc1a1456208c0d80c9079df2280c30b16bf